Edition: BP 2025 (Ph. Eur. 11.6 update)
DEFINITION
Fatty oil obtained from seeds of Borago officinalis L. by extraction and/or expression. It is then refined. A suitable antioxidant may be added.
PRODUCTION
The oil is prepared using materials and methods designed to ensure that the content of brassicasterol (2.4.23) in the sterol fraction of the oil is not greater than 0.3 per cent.
CHARACTERS
Appearance
Clear, light yellow or yellow liquid.
Solubility
Practically insoluble in water and in ethanol (96 per cent), miscible with light petroleum.
Relative density
About 0.921.
Refractive index
About 1.476.
IDENTIFICATION
First identification: B.
Second identification: A.
A. Identification of fatty oils by thin-layer chromatography (2.3.2).
Results The chromatogram obtained is similar to the corresponding chromatogram shown in Figure 2.3.2.-1.
B. Composition of fatty acids (see Tests).
TESTS
Acid value (2.5.1)
Maximum 0.5, or maximum 0.3 if intended for use in the manufacture of parenteral preparations.
Peroxide value (2.5.5, Method A)
Maximum 10.0, or maximum 5.0 if intended for use in the manufacture of parenteral preparations.
Unsaponifiable matter (2.5.7)
Maximum 2.0 per cent, determined on 5.0 g.
Alkaline impurities (2.4.19)
It complies with the test.
Composition of fatty acids (2.4.22, Method A)
Use the mixture of calibrating substances in Table 2.4.22.-3.
Composition of the fatty-acid fraction of the oil:
— saturated fatty acids of chain length less than C16: maximum 0.3 per cent;
— palmitic acid: 9.0 per cent to 12.0 per cent;
— palmitoleic acid: maximum 0.6 per cent;
— stearic acid: 2.0 per cent to 6.0 per cent;
— oleic acid: 12.0 per cent to 22.0 per cent;
— linoleic acid: 30.0 per cent to 41.0 per cent;
— gamma-linolenic acid: 17.0 per cent to 27.0 per cent;
— alpha-linolenic acid: maximum 0.5 per cent;
— arachidic acid: maximum 0.5 per cent;
— eicosenoic acid: 2.8 per cent to 4.4 per cent;
— erucic acid: maximum 3.0 per cent;
— nervonic acid: maximum 4.5 per cent.
Water (2.5.32)
Maximum 0.1 per cent, determined on 1.00 g.
STORAGE
Under an inert gas, in a well-filled, airtight container, protected from light.
LABELLING
The label states:
— where applicable, that the oil is suitable for use in the manufacture of parenteral preparations;
— the name of the inert gas.
